BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis

Carlo Selmi, Klaus Krüger, Alain Cantagrel, Miguel Angel Abad Hernández, Ulrich Freudensprung, Mourad Farouk Rezk, Janet Addison

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences